SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
|(State or other jurisdiction of||Commission File No.||(I.R.S. Employer|
|Incorporation or organization)||Identification No.)|
(Address of principal executive offices) (Zip Code)
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|Title of Each Class||Trading Symbol(s)||Name of Each Exchange on Which Registered|
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Section 5 – Corporate Governance and Management
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(d) Election of New Director
On September 3, 2020, the Board of Directors (the “Board”) of Bruker Corporation (the “Company”) approved an increase in the number of directors to expand the size of the Board by one director to a total of ten directors, with such additional director assigned to Class I, and appointed Ms. Bonnie H. Anderson to fill the newly-created vacancy on the Board, effective as of September 3, 2020. Ms. Anderson will initially serve as an independent director until the Company’s 2022 Annual Meeting of Stockholders.
Ms. Anderson’s compensation for her services as a director will be consistent with that of the other non-employee directors of the Company, as described in the Company’s definitive proxy statement with respect to its 2020 Annual Meeting of Stockholders, filed with the Securities and Exchange Commission on April 22, 2020. There are no other arrangements or understandings between Ms. Anderson and any other person pursuant to which she was appointed as a director, and there are no transactions involving the Company and Ms. Anderson that the Company would be required to report pursuant to Item 404(a) of Regulation S-K.
A copy of the press release announcing Ms. Anderson’s appointment is attached to this report as Exhibit 99.1.
Section 9 – Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
|99.1||Press release dated September 8, 2020.|
|104||Cover Page Interactive Data File (embedded within the Inline XBRL document).|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|Date: September 8, 2020||By:||/s/ Gerald N. Herman|
|Gerald N. Herman|
|Chief Financial Officer|